COMMUNIQUÉS West-GlobeNewswire

ContraVir Pharmaceuticals Completes Renal Impairment Study with TXL™
06/02/2018
EDISON, N.J., Feb. 06, 2018 (GLOBE NEWSWIRE) -- ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ), a biopharmaceutical company focused on the development and commercialization of targeted antiviral therapies, announced [...]
Transactions in relation to share buyback program
06/02/2018
Acting under its share buyback authorization, the GN Store Nord board of directors initiated a share buyback program on May 4, 2017 in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
FIT Biotech Oy: RESOLUTIONS OF EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY FEBRUARY 6, 2018
06/02/2018
Company release February 6, 2018 at 12:15 EET RESOLUTIONS OF EXTRAORDINARY GENERAL MEETING OF FIT BIOTECH OY FEBRUARY 6, 2018 The EGM of FIT Biotech Oy ("FIT Biotech", "Company") has made the following resolutions today [...]
Change of Chief Executive Officer
06/02/2018
MELBOURNE, Australia, Feb. 06, 2018 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG) (NASDAQ: GENE ) (“Company”, “GTG”), advises that the Board and Mr Eutillio Buccilli have today agreed that Mr Buccilli step [...]
Thinking About a Facelift? Announcing a Skincare Range Specifically Created for Mature Women: The Azul SkinHealth Anti-Aging System
06/02/2018
NAPLES, Fla., Feb. 06, 2018 (GLOBE NEWSWIRE) -- As any one of the thousands of “snow birds” who flock to Florida for the winter will tell you, the Sunshine State, with its enviable climate, does have a downside – skin [...]
Xbrane Biopharma signs license agreement with CR Pharma for Spherotide in China
06/02/2018
Press release 2018-02-06 Xbrane Biopharma (publ.) ("Xbrane") and China Resource Pharmaceutical Group Limited ("CR Pharma") have entered into a license agreement which gives CR Pharma exclusive rights to market and sell [...]
ALK releases its annual report 2017
06/02/2018
Copenhagen, 2018-02-06 07:30 CET (GLOBE NEWSWIRE) -- The Board of Directors of ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today considered and approved the 2017 annual report with the following highlights [1] : Q4 [...]
Santhera Launches U.S. Expanded Access Program with Idebenone for Patients with Duchenne Muscular Dystrophy (DMD)
06/02/2018
Liestal, Switzerland, February 6, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces the launch of a U.S. Expanded Access Program (EAP) referred to as BreatheDMD with idebenone for patients with DMD. Through the [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
06/02/2018
REGULATED INFORMATION GHENT, Belgium, 6 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
06/02/2018
REGULATED INFORMATION GHENT, Belgium, 6 February 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
Idorsia announces financial results for 2017 - company off to a great start - 4 compounds to enter Phase 3 development
06/02/2018
Allschwil, Switzerland - 06 February 2018 - Idorsia Ltd (SIX: IDIA) today announced its financial results as of December 31, 2017, which represent the business activities for the six and a half months since the demerger [...]
Targovax ASA: Invitation to fourth quarter and full year 2017 results presentation Thursday 15 February
06/02/2018
Oslo, Norway, 6 February 2018 - Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, will announce its fourth quarter 2018 results on Thursday, 15 [...]
BCPhA Response to B.C. Government Retail Framework for Non-Medical Cannabis
06/02/2018
VANCOUVER, British Columbia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- The BC Pharmacy Association (BCPhA) applauds the B.C. Government’s decision to make a clear distinction between non-medical cannabis and medical cannabis by [...]
Burcon NutraScience Announces Transfer of Listing to Nasdaq Capital Market
06/02/2018
VANCOUVER, British Columbia, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Company”), a leader in natural product extraction, purification and isolation [...]
Correction from source: Aurora Spine Announces Upsizing of Private Placement
06/02/2018
CARLSBAD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (TSX-V: ASG ) ("Aurora Spine" or the "Company") is pleased to announce that, as a result of strong investor demand, it has increased the size [...]
BeiGene Announces Commercial Availability of VIDAZA® (Azacitidine for Injection) in China
06/02/2018
BEIJING, China, and CAMBRIDGE, Mass., Feb. 05, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]
Aurora Spine Announces Upsizing of Private Placement
05/02/2018
CARLSBAD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE [...]
Ari Kellen Acquires Common Shares of Vaxil Bio Ltd.
05/02/2018
TORONTO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- Ari Kellen announces that on January 26, 2018, he acquired (the " Acquisition ") by way of private placement ownership over 4,985,000 units (" Units ") of Vaxil Bio Ltd. (TSXV: [...]
BeiGene to Present Tislelizumab Data in Urothelial Carcinoma at the 2018 Genitourinary Cancers Symposium
05/02/2018
CAMBRIDGE, Mass. and BEIJING, China, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE ), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly [...]

Pages